Premium
Long‐term Efficacy and Toxicity of High‐ and Low‐Dose Amiodarone Regimens
Author(s) -
Kerin Nicholas Z.,
Aragon Eric,
Faitel Kathy,
Frumin Howard,
Rubernfire Melvyn
Publication year - 1989
Publication title -
the journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.92
H-Index - 116
eISSN - 1552-4604
pISSN - 0091-2700
DOI - 10.1002/j.1552-4604.1989.tb03354.x
Subject(s) - medicine , toxicity , amiodarone , term (time) , pharmacology , oncology , atrial fibrillation , physics , quantum mechanics
Amiodarone is an effective antiarrhythmic drug for the control of potentially lethal and lethal ventricular arrhythmias (VA). In the United States, a high‐dose regimen has been used at the expense of a high toxicity profile for the control of lethal VAs. Significant antiarrhythmic efficacy has also been established with low‐dose regimens, which carry a low rate of intolerable side effects (5.4%) when compared with the high‐dose regimen (16.7%). The high incidence of tolerable and intolerable adverse side effects is probably related to high amiodarone loading (31.92 g) and maintenance doses (520 mg/d). In contrast, the low‐dose regimen uses much lower loading (7.2 g) and maintenance (280 mg/d) doses.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom